Aurobindo Pharma Limited, Unit VII vs Boston Scientific Corporation: FDA Enforcement Comparison

Boston Scientific Corporation has been the subject of 285 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Aurobindo Pharma Limited, Unit VII.

Aurobindo Pharma Limited, Unit VII: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Boston Scientific Corporation: 0 warning letters, 285 recalls, 0 approval records, 0 Form 483s.

Side by side

Aurobindo Pharma Limited, Unit VII — Warning letters0

Boston Scientific Corporation — Warning letters0

Aurobindo Pharma Limited, Unit VII — Recalls0

Boston Scientific Corporation — Recalls285

Aurobindo Pharma Limited, Unit VII — Approval records0

Boston Scientific Corporation — Approval records0

Aurobindo Pharma Limited, Unit VII — Form 483s1

Boston Scientific Corporation — Form 483s0

Timeline

Aurobindo Pharma Limited, Unit VII

Most recent FDA action: February 10, 2026

Full history →

Boston Scientific Corporation

Most recent FDA action: August 12, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Aurobindo Pharma Limited, Unit VII vs Boston Scientific Corporation: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/aurobindo-pharma-limited-unit-vii-vs-boston-scientific-corporation

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗